These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7834807)

  • 1. N-acetylation and N-formylation of carcinogenic arylamines and related compounds in dogs.
    Okumura F; Ueda O; Kitamura S; Tatsumi K
    Carcinogenesis; 1995 Jan; 16(1):71-6. PubMed ID: 7834807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study on metabolic formation of N-arylformamides and N-arylacetamides from carcinogenic arylamines in mammalian species.
    Tatsumi K; Kitamura S; Amano H; Ueda K
    Cancer Res; 1989 Apr; 49(8):2059-64. PubMed ID: 2702648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases.
    Flammang TJ; Kadlubar FF
    Carcinogenesis; 1986 Jun; 7(6):919-26. PubMed ID: 3708755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetyl coenzyme A dependent activation of N-hydroxy derivatives of carcinogenic arylamines: mechanism of activation, species difference, tissue distribution, and acetyl donor specificity.
    Shinohara A; Saito K; Yamazoe Y; Kamataki T; Kato R
    Cancer Res; 1986 Sep; 46(9):4362-7. PubMed ID: 3731093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of dog bladder mucosa in the N-oxidation of arylamines.
    Brill E
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):73-84. PubMed ID: 841183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon.
    Turesky RJ; Lang NP; Butler MA; Teitel CH; Kadlubar FF
    Carcinogenesis; 1991 Oct; 12(10):1839-45. PubMed ID: 1934265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylation of 2-aminofluorene derivatives by dog hepatic microsomes.
    Sone T; Zukowski K; Land SJ; King CM; Wang CY
    Carcinogenesis; 1991 Oct; 12(10):1887-91. PubMed ID: 1934270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of cytochrome P450 1A2-mediated formation of N-hydroxy arylamines and heterocyclic amines and their reaction with guanyl residues.
    Guengerich FP; Humphreys WG; Yun CH; Hammons GJ; Kadlubar FF; Seto Y; Okazaki O; Martin MV
    Princess Takamatsu Symp; 1995; 23():78-84. PubMed ID: 8844798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s).
    Chou HC; Lang NP; Kadlubar FF
    Cancer Res; 1995 Feb; 55(3):525-9. PubMed ID: 7834621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variation in N-acetylation of carcinogenic arylamines by human and rabbit liver.
    Glowinski IB; Radtke HE; Weber WW
    Mol Pharmacol; 1978 Sep; 14(5):940-9. PubMed ID: 714030
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of repair synthesis of DNA in mammary and urinary bladder epithelial cells by N-hydroxy derivatives of carcinogenic arylamines.
    Wang CY; Yamada H; Morton KC; Zukowski K; Lee MS; King CM
    Cancer Res; 1988 Aug; 48(15):4227-32. PubMed ID: 3390817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of 1-nitropyrene by human, rat, and mouse intestinal flora: mutagenicity of isolated metabolites by direct analysis of HPLC fractions with a microsuspension reverse mutation assay.
    King LC; Kohan MJ; George SE; Lewtas J; Claxton LD
    J Toxicol Environ Health; 1990 Nov; 31(3):179-92. PubMed ID: 2231777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reductive metabolism of stilbene oxide and styrene oxide to the olefins in rats.
    Kitamura S; Shiraishi Y; Mita M; Sueki H; Maeda C; Tatsumi K
    Biol Pharm Bull; 2000 Feb; 23(2):265-8. PubMed ID: 10706400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic N-oxidation of carcinogenic arylamines in relation to nitrogen charge density and oxidation potential.
    Kadlubar FF; Fu PP; Jung H; Shaikh AU; Beland FA
    Environ Health Perspect; 1990 Jul; 87():233-6. PubMed ID: 2269230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the intestinal microflora in the formation of DNA and haemoglobin adducts in rats treated with 2-nitrofluorene and 2-aminofluorene by gavage.
    Scheepers PT; Velders DD; Steenwinkel MJ; van Delft JH; Driessen W; Stratemans MM; Baan RA; Koopman JP; Noordhoek J; Bos RP
    Carcinogenesis; 1994 Jul; 15(7):1433-41. PubMed ID: 8033322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further metabolism of 2-formylaminofluorene, a metabolite of 2-aminofluorene, in rats.
    Ueda O; Kitamura S; Tatsumi K
    Biol Pharm Bull; 1996 Feb; 19(2):330-3. PubMed ID: 8850336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human arylamine N-acetyltransferase 1: in vitro and intracellular inactivation by nitrosoarene metabolites of toxic and carcinogenic arylamines.
    Liu L; Wagner CR; Hanna PE
    Chem Res Toxicol; 2008 Oct; 21(10):2005-16. PubMed ID: 18759501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of nitropolycyclic aromatic hydrocarbons by human intestinal microflora.
    Cerniglia CE; Howard PC; Fu PP; Franklin W
    Biochem Biophys Res Commun; 1984 Aug; 123(1):262-70. PubMed ID: 6477581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation of N-hydroxylated metabolites of carcinogenic and mutagenic arylamines and arylamides by esterification.
    Kato R; Yamazoe Y
    Drug Metab Rev; 1994; 26(1-2):413-29. PubMed ID: 8082577
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.